Skip to main content
OpenTrials

Clinical trial condition

Rhinitis, Allergic, Seasonal

Explore clinical trials studying Rhinitis, Allergic, Seasonal. Study availability and eligibility vary by location and protocol.

353 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Rhinitis, Allergic, Seasonal trial results

Completed

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

NCT05590598

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Sandoz Investigative Site Chelyabinsk, Russia
  • Sandoz Investigative Site Khasavyurt, Russia
  • Sandoz Investigative Site Krasnodar, Russia
  • Sandoz Investigative Site Nal'chik, Russia
View all 15 locations
View Trial Details
Completed

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

NCT05311475

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Sandoz Investigative Site Burgas, Bulgaria
  • Sandoz Investigative Site Gabrovo, Bulgaria
  • Sandoz Investigative Site Plovdiv, Bulgaria
  • Sandoz Investigative Site Sliven, Bulgaria
View all 28 locations
View Trial Details
Completed

Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

NCT05234580

Conditions
Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Shijitan Hospital Beijing, Beijing Municipality, China
  • Beijing TongRen Hospital Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details
Completed

Intralymphatic Immunotherapy in Increasing Doses, Substudy

NCT02975479

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Lund Lund, Sweden
  • ENT-department, Karolinska University Hospital Huddinge (ENT-department B51) Stockholm, Sweden
View Trial Details

Related conditions